Huibo Li

583 total citations
34 papers, 457 citations indexed

About

Huibo Li is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Huibo Li has authored 34 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Huibo Li's work include Chemical Synthesis and Characterization (7 papers), MicroRNA in disease regulation (6 papers) and Radioactive element chemistry and processing (6 papers). Huibo Li is often cited by papers focused on Chemical Synthesis and Characterization (7 papers), MicroRNA in disease regulation (6 papers) and Radioactive element chemistry and processing (6 papers). Huibo Li collaborates with scholars based in China and United States. Huibo Li's co-authors include Jian‐Gong Ma, Peng Cheng, Teng Ma, Ling Xu, Genshuan Wei, Dong Han, Pu Xiao, Jing Peng, Maolin Zhai and Chao Yang and has published in prestigious journals such as Blood, Journal of Hazardous Materials and Langmuir.

In The Last Decade

Huibo Li

28 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huibo Li China 9 167 93 93 87 74 34 457
Dalin Hu China 11 143 0.9× 234 2.5× 57 0.6× 99 1.1× 89 1.2× 32 586
Zhong‐Lin Li China 13 74 0.4× 84 0.9× 279 3.0× 177 2.0× 38 0.5× 66 594
Haiming Cheng China 13 119 0.7× 42 0.5× 147 1.6× 104 1.2× 16 0.2× 38 500
Jingjing Qian United States 10 123 0.7× 42 0.5× 72 0.8× 166 1.9× 28 0.4× 22 416
Lan Wu China 16 205 1.2× 33 0.4× 122 1.3× 147 1.7× 18 0.2× 32 636
Yu China 15 141 0.8× 84 0.9× 122 1.3× 86 1.0× 30 0.4× 107 745
Jing-Hao Liu China 9 70 0.4× 48 0.5× 249 2.7× 220 2.5× 71 1.0× 12 466
Zhirou Wang China 10 164 1.0× 88 0.9× 18 0.2× 39 0.4× 43 0.6× 12 427
Zhuo Huang China 13 102 0.6× 62 0.7× 128 1.4× 190 2.2× 25 0.3× 40 549

Countries citing papers authored by Huibo Li

Since Specialization
Citations

This map shows the geographic impact of Huibo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibo Li more than expected).

Fields of papers citing papers by Huibo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huibo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibo Li. The network helps show where Huibo Li may publish in the future.

Co-authorship network of co-authors of Huibo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huibo Li. A scholar is included among the top collaborators of Huibo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huibo Li. Huibo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yuzhu, Li Guo, Peng Nie, et al.. (2025). Targeting BACH1 by HPPE inhibits the Wnt/β-catenin pathway and malignant phenotype in glioblastoma cells. APOPTOSIS. 30(11-12). 2848–2867.
3.
Wang, Ning, et al.. (2025). The Exploration of Disturbance of Capillary and Photoreceptor Communication Networks in Diabetic Retinopathy Through Single‐Cell RNA‐Seq. Journal of Cellular and Molecular Medicine. 29(5). e70442–e70442. 3 indexed citations
4.
Song, Jingyu, Jie Liu, Dan Guo, Huibo Li, & Shengjin Fan. (2024). Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases. Transplant Immunology. 87. 102119–102119.
5.
Li, Huibo, et al.. (2024). Advances in the ocular complications after hematopoietic stem cell transplantation. Annals of Hematology. 103(10). 3867–3880.
6.
Li, Huibo, et al.. (2023). Tailored Sky‐Parking Architectures of 3D Graphene Oxide Towards Highly‐Efficient Water Purification. ChemSusChem. 16(7). e202201974–e202201974. 2 indexed citations
7.
Sun, Jiayang, Yinyong Ao, Yue Wang, et al.. (2023). Effect of radiolysis and radiolytic products of tri-iso-amyl phosphate on the extraction behavior of uranium. Journal of Radioanalytical and Nuclear Chemistry. 332(10). 4089–4099. 2 indexed citations
8.
Li, Huibo, Jinxiao Hou, Yueyue Fu, et al.. (2023). miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia. Annals of Hematology. 102(12). 3357–3367. 3 indexed citations
10.
Fu, Yueyue, Limin Li, Jinxiao Hou, et al.. (2021). miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT. Journal of Oncology. 2021. 1–9. 3 indexed citations
11.
Chen, Xi, Shengjin Fan, Lili Sun, et al.. (2019). Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia. Pathology - Research and Practice. 215(8). 152494–152494. 4 indexed citations
12.
Sun, Lili, Huibo Li, Desheng Kong, et al.. (2018). Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration. Journal of Translational Medicine. 16(1). 361–361. 48 indexed citations
13.
Kong, Desheng, Linlin Zhao, Lili Sun, et al.. (2018). MYCN is a novel oncogenic target in adult B‐ALL that activates the Wnt/β‐catenin pathway by suppressing DKK3. Journal of Cellular and Molecular Medicine. 22(7). 3627–3637. 19 indexed citations
14.
Li, Huibo, et al.. (2017). Photo-responsive nanoparticles for β-lapachone delivery in vitro. Chinese Chemical Letters. 29(9). 1347–1349. 5 indexed citations
15.
Zhang, Yingjie, Huibo Li, Lili Sun, et al.. (2017). Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all. Oncotarget. 8(38). 64114–64128. 15 indexed citations
16.
Xiao, Pu, Dong Han, Maolin Zhai, Ling Xu, & Huibo Li. (2016). Comparison with adsorption of Re (VII) by two different γ-radiation synthesized silica-grafting of vinylimidazole/4-vinylpyridine adsorbents. Journal of Hazardous Materials. 324(Pt B). 711–723. 54 indexed citations
17.
Li, Huibo, Gang Cui, Shengjin Fan, et al.. (2015). Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells. International Journal of Hematology. 102(5). 558–568. 11 indexed citations
18.
Qi, Yinyan, et al.. (2013). Anatomical and biochemical studies of bicolored flower development in Muscari latifolium. PROTOPLASMA. 250(6). 1273–1281. 37 indexed citations
19.
Zhou, Jin, Huibo Li, Yueyue Fu, et al.. (2011). Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells. Thrombosis Research. 127(5). 466–472. 6 indexed citations
20.
Qiu, Jingyi, Huibo Li, Ling Xu, et al.. (2008). Adsorption of Cr(VI) using silica-based adsorbent prepared by radiation-induced grafting. Journal of Hazardous Materials. 166(1). 270–276. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026